Geerts W. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition)/ W. Geerts, D Bergqvist, G.F. PineoJ.A. Heit, C.M. Samama, M.R. Lassen, C.W. Colwell // Chest. - 2008. - 133 (6). - P.381S-453S.

Ageno W. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry / W Ageno, N Riva, S Schulman, et al. // SeminThrombHemost. - 2014.- Feb;40(l). - P.99-105.

Molteni M. Warfarin and atrial fibrillation: from ideal to real the warfarin affaire/ M. Molteni, C. Cimminiello // Thromb J. - 2014. - 12(1). - P.5.; VoT., 2014.

Vo T. Current state of anticoagulants to treat deep venous thrombosis / T. Vo, S. Vazquez, M.T. Rondina // CurrCardiol Rep. -2014. -16(3). -P.463.

Verhaeghe R., DeMoerloose P., Eikenboom J.C. et al. Genetic and asquired risk factors of venous thromboembolism. In: Pulmonary Vascular Pathology: A Clinical Update. Eds. M. Demedts, M. Delcroix, R. Verhaeghe, G.M. Verleden. EurRespSoc 2004. –С. 9.

Wang Z.M., Li L., Zheng B.S., Normakhamatov N., GuoS.Y. Preparation and anticoagulation activity of sodium cellulose sulfate // Int. J. Biol. Macromol. 2007. Vol.41 (2). -P. 376-382.

Huynh R., Chaubet F., Jozefonvicz J. Anticoagulant properties of dextranmethylcarboxylatebenzylamide sulfate (DMCBSu); a new generation of bioactive functionalized dextran // Carbohydr. Res. 2001. Vol. 332. -P. 75-83. 10.

Mahner C., Lechner M. D., Nordmeier E. Synthesis and characterization of dextran and pullulan sulphate // Carbohydr. Res. 2001. Vol. 331. -P. 203-208.